Damage and Repair in Cancer Development and Cancer Treatment (DARE)

University of Groningen > Faculteit Medische Wetenschappen/UMCG > Cancer Research Center Groningen (CRCG) > Damage and Repair in Cancer Development and Cancer Treatment (DARE)

  1. 2020
  2. Paganetti, H., Beltran, C. J., Both, S., Dong, L., Flanz, J. B., Furutani, K. M., Grassberger, C., Grosshans, D. R., Knopf, A-C., Langendijk, J. A., Nyström, H., Parodi, K., Raaymakers, B. W., Richter, C., Sawakuchi, G. O., Schippers, J. M., Shaitelman, S. F., Teo, K., Unkelbach, J., ... Lomax, A. J. (2020). Roadmap: proton therapy physics and biology. Physics in Medicine and Biology. https://doi.org/10.1088/1361-6560/abcd16
  3. Coca-Pelaz, A., Mäkitie, A. A., Strojan, P., Corry, J., Eisbruch, A., Beitler, J. J., Nuyts, S., Smee, R., Langendijk, J. A., Mendenhall, W. M., Piazza, C., Rinaldo, A., & Ferlito, A. (2020). Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review. Advances in therapy. https://doi.org/10.1007/s12325-020-01556-y
  4. Koopman, B., Groen, H. J. M., Ligtenberg, M. J. L., Grünberg, K., Monkhorst, K., de Langen, A. J., Boelens, M. C., Paats, M. S., Von der Thüsen, J. H., Dinjens, W. N. M., Solleveld, N., Van Wezel, T., Gelderblom, H., Hendriks, L. E., Speel, E-J. M., Theunissen, T. E., Kroeze, L. I., Mehra, N., Piet, B., ... van Kempen, L. (2020). Multicenter comparison of Molecular Tumor Boards in the Netherlands: definition, composition, methods and targeted therapy recommendations. The Oncologist. https://doi.org/10.1002/onco.13580
  5. Wolf, J., Overbeck, T., Han, J. -Y., Hochmair, M., De Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., & Heist, R. S. (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. Oncology Research and Treatment, 43(SUPPL 4), 150-151.
  6. Wolf, J., Groen, H. J. M., Akerley, W., Souquet, P. -J., Laack, E., Han, J. -Y., Smit, E. F., Mansfield, A. S., Garon, E. B., Tan, D. S. W., Heist, R. S., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., & Orlov, S. (2020). Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small- cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study. Oncology Research and Treatment, 43(SUPPL 4), 143-143. https://doi.org/10.1200/JCO.2020.38.15_suppl.9520
  7. Lebbink, C. A., Dekker, B. L., Bocca, G., Braat, A. J. A. T., Derikx, J. P. M., Dierselhuis, M. P., de Keizer, B., Kruijff, S., Kwast, A. B. G., van Nederveen, F. H., van Dijkum, E. J. M. N., Nievelstein, R. A. J., Peeters, R. P., van Scheltinga, C. E. J. T., Tissing, W. J. E., van der Tuin, K., Vriens, M. R., Zsiros, J., van Trotsenburg, A. S. P., ... van Santen, H. M. (2020). New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands. European Journal of Endocrinology, 183(4), P11-P18. https://doi.org/10.1530/EJE-20-0191
  8. Perakis, S. O., Weber, S., Zhou, Q., Graf, R., Hojas, S., Riedl, J. M., Gerger, A., Dandachi, N., Balic, M., Hoefler, G., Schuuring, E., Groen, H. J. M., Geigl, J. B., Heitzer, E., & Speicher, M. R. (2020). Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer. ESMO Open, 5(5), [000872]. https://doi.org/10.1136/esmoopen-2020-000872, https://doi.org/10.1136/esmoopen-2020-000872
  9. Valstar, M. H., de Bakker, B. S., Steenbakkers, R. J. H. M., de Jong, K. H., Smit, L. A., Klein Nulent, T. J. W., van Es, R. J. J., Hofland, I., de Keizer, B., Jasperse, B., Balm, A. J. M., van der Schaaf, A., Langendijk, J. A., Smeele, L. E., & Vogel, W. V. (2020). The tubarial salivary glands: first description of a potential new organ at risk for head-neck radiotherapy. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2020.09.034
  10. GEOMETRY Mono-1, Wolf, J., Seto, T., Han, J-Y., Reguart, N., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S. V., Smit, E. F., Souquet, P-J., Vansteenkiste, J., Hochmair, M., Felip, E., Nishio, M., Thomas, M., Ohashi, K., ... Heist, R. S. (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. New England Journal of Medicine, 383(10), 944-957. https://doi.org/10.1056/NEJMoa2002787
  11. Reumkens, K., Tummers, M. H. E., Severijns, Y., Gietel-Habets, J. J. G., van Kuijk, S. M. J., Aalfs, C. M., van Asperen, C. J., Ausems, M. G. E. M., Collee, M., Dommering, C. J., Kets, M., van der Kolk, L. E., Oosterwijk, J. C., Tjan-Heijnen, V. C. G., van der Weijden, T., de Die-Smulders, C. E. M., & van Osch, L. A. D. M. (2020). Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. Journal of community genetics. https://doi.org/10.1007/s12687-020-00484-2
  12. van Santen, H. M., Alexander, E. K., Rivkees, S. A., Frey, E., Clement, S. C., Dierselhuis, M. P., Lebbink, C. A., Links, T. P., Lorenz, K., Peeters, R. P., Reiners, C., Vriens, M. R., Nathan, P., Schneider, A. B., & Verburg, F. (2020). Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors. European Journal of Endocrinology, 183(3), P1-P10. https://doi.org/10.1530/EJE-20-0237
  13. Familial MRI Screening (FaMRIsc) Study group, Geuzinge, H. A., Obdeijn, I-M., Rutgers, E. J. T., Saadatmand, S., Mann, R. M., Oosterwijk, J. C., Tollenaar, R. A. E. M., de Roy van Zuidewijn, D. B. W., Lobbes, M. B. I., van 't Riet, M., Hooning, M. J., Ausems, M. G. E. M., Loo, C. E., Wesseling, J., Luiten, E. J. T., Zonderland, H. M., Verhoef, C., Heijnsdijk, E. A. M., ... de Koning, H. J. (2020). Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk. JAMA oncology, 6(9), 1381-1389. https://doi.org/10.1001/jamaoncol.2020.2922
  14. Gelderblom, H., Gietema, J. A., Desar, I. M. E., Ajmone, N. M., Jalving, M., Kroep, J. R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S. F., & Damstrup, L. (2020). First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Annals of Oncology, 31, S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715
  15. Joode, K. D., Groen, H. J. M., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., de Groot, J. W. B., de Wijn, R., Hurkmans, D. P., van den Heuvel, D. M. A., Schmidt, K., Groten, J. P., Verdegaal, E. M. E., van der Burg, S. H., van den Heuvel, M. M., Aerts, J. G. J. V., Kapiteijn, E., & Mathijssen, R. H. (2020). Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC. Annals of Oncology, 31, S788-S788. https://doi.org/10.1016/j.annonc.2020.08.094
  16. Benedict, B., van Bueren, M. A., van Gemert, F. P., Lieftink, C., Guerrero Llobet, S., van Vugt, M. A., Beijersbergen, R. L., & Te Riele, H. (2020). The RECQL helicase prevents replication fork collapse during replication stress. Life science alliance, 3(10), [e202000668]. https://doi.org/10.26508/lsa.202000668
  17. Nabuurs, C. H., Kievit, W., BSc, N. L., Leemans, C. R., Smit, C. F. G. M., van den Brekel, M. W. M., Pauw, R. J., van der Laan, B. F. A. M., Jansen, J. C., Lacko, M., Braunius, W. W., Morita, S., Wierzbicka, M., Matoba, T., Hanai, N., Takes, R. P., & Kunst, H. P. M. (2020). Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal. Journal of the Sciences and Specialties of the Head and Neck, (12), 3609-3622. https://doi.org/10.1002/hed.26424
Previous 1 2 3 4 5 6 7 8 ...76 Next

ID: 36459